Dr. Sam F. Daneshvari, M.D.
Nephrology (Kidney) (Nephrology Physician)
1505 Wilson Ter, Suite #155
Glendale, CA 91206
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Southern California Keck School of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,145
Licensed in California since 1996, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: University of Southern California Keck School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
CA license A60891 (first issued 1996; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Usc Verdugo Hills Hospital Glendale, CA
- Glendale Adventist Medical Center Glendale, CA
- Northridge Hospital Medical Center Northridge, CA
- Glendale Mem Hospital & Hlth Center Glendale, CA
- Hollywood Presbyterian Medical Center Los Angeles, CA
Medical groups
- Kidney Disease Medical Group Inc (8 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,145
- Services billed
- 9,444
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 3,785 | 14 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 2,627 | 642 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 680 | 80 |
| Established patient office or other outpatient visit, 30-39 minutes | 583 | 252 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 416 | 365 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 393 | 78 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 310 | 64 |
| Injection of drug or substance under skin or into muscle | 68 | 13 |
| New patient office or other outpatient visit, 45-59 minutes | 39 | 39 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 33 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prosol (parenteral amino acid 20% no.1) | 175 |
| Hydralazine Hcl Other prescribers in Glendale, CA | 144 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Glendale, CA | 127 |
| Amlodipine Besylate Other prescribers in Glendale, CA | 126 |
| Furosemide Other prescribers in Glendale, CA | 123 |
| Losartan Potassium Other prescribers in Glendale, CA | 105 |
| Calcitriol Other prescribers in Glendale, CA | 62 |
| Febuxostat Other prescribers in Glendale, CA | 60 |
| Olmesartan Medoxomil Other prescribers in Glendale, CA | 46 |
| Ramipril Other prescribers in Glendale, CA | 44 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 30 payments worth $687 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $201 |
|---|---|
| Vifor Pharma, Inc. | $85.72 |
| Otsuka America Pharmaceutical, Inc. | $66.30 |
| Novartis Pharmaceuticals Corporation | $64.84 |
| Amgen Inc. | $49.82 |
| Aurinia Pharma U.S., Inc. | $43.62 |
| Novo Nordisk Inc | $35.37 |
| GlaxoSmithKline, LLC. | $29.14 |
| Food and Beverage | $687 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $160,215 in research payments for these studies, mostly to the institutions running them.
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Csl Behring · Recruiting · NCT05485961 - A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients…
Alnylam Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.